+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gynecological Contraceptive Implant Market - Global Forecast 2026-2032- Product Image
Gynecological Contraceptive Implant Market - Global Forecast 2026-2032- Product Image
Sale

Gynecological Contraceptive Implant Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122836
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gynecological Contraceptive Implant Market is projected to reach USD 475.52 Million in 2026. It is expected to continue growing at a CAGR of 5.52%, reaching USD 657.19 Million by 2032.

Gynecological Contraceptive Implants: Executive Overview

Gynecological contraceptive implants are long-acting reversible contraceptive devices placed under the skin and designed to release a progestin over an extended period. Their clinical value centers on high user effectiveness, reversibility, discreet use, and reduced dependence on daily adherence. Market development is shaped by contraceptive counseling, provider training, insertion and removal capacity, product access, affordability, and informed patient choice.

Access, Counseling, and Service Integration Are Reshaping Adoption

The landscape is shifting from product availability alone toward integrated reproductive-health delivery. Programs increasingly emphasize voluntary, rights-based counseling, method choice, postpartum and post-abortion access where clinically appropriate, and reliable follow-up for side-effect management and removal. Training task sharing, standardized insertion and removal protocols, procurement continuity, and integration with primary care can improve service resilience, while concerns about bleeding changes, informed consent, privacy, and discontinuation require transparent communication.

Artificial Intelligence Can Strengthen Contraceptive Services Without Replacing Clinical Judgment

Artificial intelligence can support demand planning, inventory monitoring, appointment prioritization, multilingual education, and identification of service gaps when trained on representative, governed data. Decision-support tools may help clinicians apply eligibility guidance and identify follow-up needs, but they should not replace examination, shared decision-making, or consent. Bias testing, privacy safeguards, cybersecurity, explainability, and human oversight are essential, particularly where reproductive-health data may expose patients to stigma or harm.

Regional Insights: Uneven Access Calls for Locally Adapted Delivery Models

North America is characterized by established clinical infrastructure alongside affordability, insurance coverage, and reproductive-care access differences. Latin America benefits from strong interest in reversible contraception but faces persistent inequities in counseling quality, public-sector availability, and rural access. Europe generally combines mature health systems with varied reimbursement and national guidance. The Middle East requires culturally responsive counseling and attention to policy and service variation. Africa’s priorities include commodity security, trained providers, task sharing, and youth-friendly delivery. Asia-Pacific spans highly diverse regulatory, demographic, and health-system contexts, making country-specific procurement and service models essential.

Group Insights: Regional Blocs Differ in Policy Coordination and Health-System Capacity

ASEAN countries show substantial variation in public-health financing, urbanization, regulatory pathways, and contraceptive delivery capacity, favoring adaptable national strategies. BRICS members combine large and diverse populations with differing public and private healthcare roles, making local manufacturing, procurement, and provider-network considerations important. The European Union benefits from shared principles but retains national differences in reimbursement and clinical implementation. G7 systems generally have advanced infrastructure, yet affordability and equity gaps remain. GCC countries require approaches aligned with expatriate and citizen populations, cultural context, and centralized health services. NATO members span diverse healthcare systems, so alliance membership should not be treated as a proxy for contraceptive access.

Country Insights: Implementation Priorities Vary Across the Covered Markets

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally have established clinical systems, but access depends on reimbursement, provider availability, regional disparities, and counseling quality. Brazil, Mexico, India, China, and Russia present large and diverse service environments in which public-sector reach, regulatory processes, affordability, and rural provision are important considerations. Across all covered countries, programs should protect voluntary choice, ensure timely removal, address method-related bleeding concerns, and monitor access by age, geography, income, and other relevant equity dimensions.

Practical Priorities for Leaders Building Responsible Implant Services

Industry leaders should prioritize reliable procurement, transparent evidence-based counseling, and investment in insertion and removal training. Partnerships with public providers, primary-care networks, pharmacies where permitted, and community organizations can extend reach while preserving clinical standards. Organizations should establish indicators for method initiation, continuation, complications, removals, stock availability, waiting times, patient experience, and informed-choice quality. Digital and AI tools should be introduced through controlled pilots with privacy impact assessments, bias monitoring, clear escalation routes, and clinician accountability. Reimbursement engagement and affordability programs should focus on reducing access barriers rather than encouraging use without informed consent.

Research Methodology: Evidence-Led Assessment of Access and Service Dynamics

This executive summary applies a structured qualitative framework to the gynecological contraceptive implant landscape. It considers clinical attributes, contraceptive-service delivery, regulatory and reimbursement environments, provider capacity, patient experience, equity, procurement, and responsible technology use. Regional, group, and country comparisons are framed as contextual interpretations rather than quantitative rankings. Conclusions should be validated against current clinical guidance, national policies, regulatory records, health-system data, peer-reviewed evidence, and interviews with qualified stakeholders before operational decisions are made.

Conclusion: Sustainable Progress Depends on Choice, Quality, and Continuity

Gynecological contraceptive implants can contribute meaningfully to voluntary, effective, and reversible contraception when patients receive accurate information and dependable services. The strongest implementation models combine continuous supply, trained providers, timely removal, respectful counseling, and equity-focused monitoring. Artificial intelligence may improve planning and navigation, but responsible governance and human clinical oversight remain non-negotiable. Progress across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific will depend on adapting delivery to local health systems while maintaining consistent standards for safety, privacy, autonomy, and informed choice.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gynecological Contraceptive Implant Market, by Product
7.1. Introduction
7.2. Etonogestrel Implant
7.3. Levonorgestrel Implant
8. Gynecological Contraceptive Implant Market, by End User
8.1. Introduction
8.2. Clinic
8.3. Hospital
8.3.1. Private Hospital
8.3.2. Public Hospital
8.4. Specialty Center
9. Gynecological Contraceptive Implant Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Gynecological Contraceptive Implant Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Gynecological Contraceptive Implant Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Gynecological Contraceptive Implant Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Actavis plc
14.2. Agile Therapeutics, Inc.
14.3. Allergan plc
14.4. Amgen Inc.
14.5. AstraZeneca PLC
14.6. Bayer AG
14.7. Bristol-Myers Squibb Company
14.8. Eli Lilly and Company
14.9. Evofem Biosciences, Inc.
14.10. Gilead Sciences, Inc.
14.11. HRA Pharma
14.12. Johnson & Johnson
14.13. Merck & Co., Inc.
14.14. Mylan N.V.
14.15. Novartis AG
14.16. Novo Nordisk A/S
14.17. Pfizer Inc.
14.18. Roche Holding AG
14.19. Sanofi S.A.
14.20. Sun Pharmaceutical Industries Ltd.
14.21. Takeda Pharmaceutical Company Limited
14.22. Teva Pharmaceutical Industries Ltd.
14.23. Warner Chilcott plc
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gynecological Contraceptive Implant Market, Years Considered for the Study
FIGURE 2. Global Gynecological Contraceptive Implant Market, Research Design
FIGURE 3. Global Gynecological Contraceptive Implant Market, Research Framework
FIGURE 4. Global Gynecological Contraceptive Implant Market, Data Triangulation
FIGURE 5. Global Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gynecological Contraceptive Implant Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Gynecological Contraceptive Implant Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gynecological Contraceptive Implant Market Size, by End User, 2025 vs 2032 (%)
FIGURE 9. Global Gynecological Contraceptive Implant Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gynecological Contraceptive Implant Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Gynecological Contraceptive Implant Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gynecological Contraceptive Implant Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Gynecological Contraceptive Implant Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Gynecological Contraceptive Implant Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Gynecological Contraceptive Implant Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gynecological Contraceptive Implant Market Segmentation & Coverage
TABLE 2. Global Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Etonogestrel Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Etonogestrel Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Etonogestrel Implant Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Levonorgestrel Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Levonorgestrel Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Levonorgestrel Implant Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 11. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Specialty Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Specialty Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Specialty Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 27. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Gynecological Contraceptive Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Asia-Pacific Gynecological Contraceptive Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Asia-Pacific Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 36. Asia-Pacific Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 37. Asia-Pacific Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 38. Asia-Pacific Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 39. North America Gynecological Contraceptive Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. North America Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 41. North America Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 42. North America Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 43. North America Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 44. Latin America Gynecological Contraceptive Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Latin America Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 46. Latin America Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Latin America Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 48. Latin America Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 49. Europe Gynecological Contraceptive Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Europe Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 51. Europe Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 52. Europe Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 53. Europe Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 54. Middle East Gynecological Contraceptive Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Middle East Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 56. Middle East Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 57. Middle East Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 58. Middle East Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 59. Africa Gynecological Contraceptive Implant Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Africa Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 61. Africa Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 62. Africa Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 63. Africa Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 64. Global Gynecological Contraceptive Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. ASEAN Gynecological Contraceptive Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. ASEAN Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 67. ASEAN Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. ASEAN Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 69. ASEAN Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 70. GCC Gynecological Contraceptive Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. GCC Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 72. GCC Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. GCC Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 74. GCC Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. European Union Gynecological Contraceptive Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. European Union Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 77. European Union Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. European Union Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 79. European Union Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. BRICS Gynecological Contraceptive Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. BRICS Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 82. BRICS Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. BRICS Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 84. BRICS Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. G7 Gynecological Contraceptive Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. G7 Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 87. G7 Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. G7 Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 89. G7 Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. NATO Gynecological Contraceptive Implant Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. NATO Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 92. NATO Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. NATO Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 94. NATO Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Global Gynecological Contraceptive Implant Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. United States Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 97. United States Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 98. United States Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. United States Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 100. United States Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Canada Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 102. Canada Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 103. Canada Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Canada Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 105. Canada Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Mexico Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 107. Mexico Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 108. Mexico Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Mexico Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 110. Mexico Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. Brazil Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 112. Brazil Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 113. Brazil Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Brazil Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 115. Brazil Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. United Kingdom Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 117. United Kingdom Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 118. United Kingdom Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. United Kingdom Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 120. United Kingdom Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. Germany Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 122. Germany Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 123. Germany Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Germany Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 125. Germany Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. France Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 127. France Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. France Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. France Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 130. France Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. Russia Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 132. Russia Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 133. Russia Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Russia Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 135. Russia Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Italy Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 137. Italy Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 138. Italy Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Italy Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 140. Italy Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. Spain Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 142. Spain Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 143. Spain Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Spain Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 145. Spain Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. China Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 147. China Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 148. China Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. China Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 150. China Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. India Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 152. India Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 153. India Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. India Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 155. India Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Japan Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 157. Japan Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 158. Japan Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Japan Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 160. Japan Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Australia Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 162. Australia Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 163. Australia Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Australia Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 165. Australia Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. South Korea Gynecological Contraceptive Implant Market Size, 2017-2032 (USD Million)
TABLE 167. South Korea Gynecological Contraceptive Implant Market Size, by Product, 2017-2032 (USD Million)
TABLE 168. South Korea Gynecological Contraceptive Implant Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. South Korea Gynecological Contraceptive Implant Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 170. South Korea Gynecological Contraceptive Implant Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Global Gynecological Contraceptive Implant Market Share, by Key Player, 2025
TABLE 172. Global Gynecological Contraceptive Implant Market, Key Experts

Companies Mentioned

  • Actavis plc
  • Agile Therapeutics, Inc.
  • Allergan plc
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Evofem Biosciences, Inc.
  • Gilead Sciences, Inc.
  • HRA Pharma
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Warner Chilcott plc

Related Topics

Related Reports

Hormonal Contraceptives Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Hormonal Contraceptives Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Hormonal Contraceptives Market - Global Forecast 2026-2032 - Product Image

Hormonal Contraceptives Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Female Contraceptive Market - Global Forecast 2026-2032 - Product Image

Female Contraceptive Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Subdermal Contraceptive Implants Market - Global Strategic Business Report - Product Image

Subdermal Contraceptive Implants Market - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.